S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Emergent BioSolutions and MorphoSys Sign License Agreement to Co-Develop and Commercialize Prostate Cancer Drug Candidate ES414|
|Emergent BioSolutions Initiates Final Pivotal Study to Support Licensure of BioThrax at Large Scale|
|Emergent BioSolutions Awarded Contract to Develop a Dry Formulation of NuThrax, a Next Generation Anthrax Vaccine|
|Emergent BioSolutions to Release Third Quarter 2014 Financial Results and Conduct a Conference Call on November 6, 2014|
|Emergent BioSolutions Reports Third Quarter and Nine Month 2014 Financial Results|
|Emergent BioSolutions Seeks Expanded BioThrax Label; Submits FDA Application for Post-Exposure Prophylaxis|
|Emergent BioSolutions to Webcast Presentation at Credit Suisse 2014 Healthcare Conference|
|MorphoSys and Emergent BioSolutions Sign License Agreement to Co-Develop and Commercialize Prostate Cancer Drug Candidate ES414 (2014/8/19)|
|Elektrobit (EB) and Nuance humanize the new Audi TT (2014/10/2)|
|UPDATE: U.S. stocks: Futures slip ahead of durable-goods data (2014/9/25)|
Click above to view more mutual fund data and stats for ebs - Emergent BioSolutions Inc.